Design, power, and interpretation of studies in the standard murine model of ALSSean Scott, James Heywood, Alan Bostrom et al.|Amyotrophic Lateral Sclerosis|2008Cited by 502
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and agingFarhad Imam, Chengran Yang, Rowan Saloner et al.|Nature Medicine|2025Cited by 85
Type I PRMT inhibition protects against C9ORF72 arginine-rich dipeptide repeat toxicityAlan Premasiri, Fernando G. Vieira|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 2